We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Initiative Aims to Improve Cancer Drugs, Accelerate Rx Approvals
Initiative Aims to Improve Cancer Drugs, Accelerate Rx Approvals
February 15, 2006
The FDA has launched an interagency initiative, along with the NIH and the Centers for Medicare & Medicaid Services (CMS), to develop personalized cancer treatments and speed cancer drug approvals through the use of biomarkers.